Cambridge Healthcare & Biotech is dedicated to improving the competitive position and financial performance of its clients.   We recognise that each company is unique and that strategies that have proven successful in one company may not be optimal in another.   We also recognize that success is measured by more than just financial performance.   Hence we strive to add value in ways that matter to you, through our knowledge of your business, the relationship we build with you, and our collaborations over the short and long term.

Introducing the new source of competitive information from CH&B

The Directory of Healthcare & Biotech (DH&B)

• DH&B contains a comprehensive set of global contact data for individuals active in the life science sector.

• Constantly updated the database currently includes:

  • Profiles of 5,041 companies

  • Contact details for 23,232 people, with brief biographies for 17,596 of them

  • Porfolios for 1,167 investors cross linked to 4,563 specific investments.
     

How can it work for you?

• Access relevant data and information to conduct trade and investment research and analysis

• Identify who within which company should be targeted for specific investment or partnering opportunities

• Cross-reference people, companies, technologies, and investors rapidly to provide answers to otherwise difficult questions that traditionally may have taken hours of analyst time to research.

Cost

Access to DH&B is via Annual Subscription allowing users unrestricted access throughout the year.  The more you utilise the database the more cost-effective it becomes. Subscriptions start from £2,000 p/a based on one registered user.

LAUNCH OFFER!

Trial the database for one month for £500.00  If at the end of this period you choose to subscribe £500 will be deducted from the cost of your first annual subscription.

Contact us to find out more and to start your trial!